(Q43693346)

English

Neural mechanisms underlying peak-dose dyskinesia induced by levodopa and apomorphine are distinct: evidence from the effects of the alpha(2) adrenoceptor antagonist idazoxan.

scientific article published in July 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11481687%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Neural mechanisms underlying peak-dose dyskinesia induced by levodopa and apomorphine are distinct: evidence from the effects of the alpha(2) adrenoceptor antagonist idazoxan (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11481687%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Jonathan M. Brotchie

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11481687%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

S H Fox

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11481687%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

B Henry

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11481687%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

M P Hill

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11481687%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

D Peggs

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11481687%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

A R Crossman

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11481687%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

language of work or name

0 references

publication date

1 July 2001

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11481687%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Movement Disorders

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11481687%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11481687%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11481687%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

642-650

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11481687%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Levodopa-induced dyskinesia: review, observations, and speculations

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1148

21 January 2018

Problems with current pharmacologic treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1148

21 January 2018

A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1148

21 January 2018

Levodopa-induced dyskinesias are improved by fluoxetine

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1148

21 January 2018

Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1148

21 January 2018

A hypothesis on the pathophysiological mechanisms that underlie levodopa- or dopamine agonist-induced dyskinesia in Parkinson's disease: implications for future strategies in treatment

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1148

21 January 2018

A 2-deoxyglucose study of the effects of dopamine agonists on the parkinsonian primate brain. Implications for the neural mechanisms that mediate dopamine agonist-induced dyskinesia

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1148

21 January 2018

Internal globus pallidus discharge is nearly suppressed during levodopa-induced dyskinesias

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1148

21 January 2018

The alpha2-adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti-parkinsonian actions of L-dopa in the MPTP-lesioned primate model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1148

21 January 2018

Effects of an alpha2 antagonist ina 20-year-old Java monkey with MPTP-induced parkinsonian signs

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1148

21 January 2018

Distribution of alpha 2-adrenergic receptor subtype gene expression in rat brain

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1148

21 January 2018

Adrenergic alpha2C-receptors reside in rat striatal GABAergic projection neurons: comparison of radioligand binding and immunohistochemistry

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1148

21 January 2018

Chronic L-DOPA administration induces dyskinesias in the 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine-treated common marmoset (Callithrix Jacchus).

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1148

21 January 2018

Levodopa-induced dyskinesias in Parkinson's disease: clinical and pharmacological classification

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1148

21 January 2018

Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1148

21 January 2018

The pharmacokinetics and metabolism of idazoxan in the rat.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1148

21 January 2018

Characterisation of dyskinesias induced by L-dopa in MPTP-treated squirrel monkeys

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1148

21 January 2018

Apomorphine test to predict dopaminergic responsiveness in parkinsonian syndromes

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1148

21 January 2018

Comparison of motor response to apomorphine and levodopa in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1148

21 January 2018

Neuropharmacological studies in rodents on the action of RX 781094, a new selective α2-adrenoceptor antagonist

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1148

21 January 2018

The adrenergic receptor agonist, clonidine, potentiates the anti-parkinsonian action of the selective kappa-opioid receptor agonist, enadoline, in the monoamine-depleted rat

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1148

21 January 2018

Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1148

21 January 2018

Differential modulation of (+)-amphetamine-induced rotation in unilateral substantia nigra-lesioned rats by alpha 1 as compared to alpha 2 agonists and antagonists.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1148

21 January 2018

Noradrenoceptor antagonism with idazoxan improves L-dopa-induced dyskinesias in MPTP monkeys

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1148

21 January 2018

The relative importance of dopamine and noradrenaline receptor stimulation for the restoration of motor activity in reserpine or alpha-methyl-p-tyrosine pre-treated mice

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1148

21 January 2018

The interaction of clonidine with dopamine-dependent behaviour in rodents

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1148

21 January 2018

Idazoxan is ineffective for levodopa-induced dyskinesias in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1148

21 January 2018

Strategies for treating patients with advanced Parkinson's disease with disastrous fluctuations and dyskinesias

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1148

21 January 2018

Activity of pallidal neurons in the monkey during dyskinesia induced by injection of bicuculline in the external pallidum

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1148

21 January 2018

Effect of nondopaminergic drugs on L-dopa-induced dyskinesias in MPTP-treated monkeys.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1148

21 January 2018

Ophthalmoplegia and leg myorhythmia in Whipple's disease: report of a case

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1148

21 January 2018

Apomorphine responses in Parkinson's disease and the pathogenesis of motor complications

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1148

21 January 2018

Challenge tests to predict the dopaminergic response in untreated Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1148

21 January 2018

Dramatic synergism between MK-801 and clonidine with respect to locomotor stimulatory effect in monoamine-depleted mice

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1148

21 January 2018

Clonidine and the anti-parkinsonian response to L-DOPA or piribedil

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1148

21 January 2018

Identifiers

10.1002/MDS.1148

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11481687%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11481687%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43693346&oldid=2102625112"